Roche has announced its acquisition of Vienna-based diabetes-management platform mySugr as part of an effort to expand its diabetes-diagnostics business. Following the transaction, for which terms were undisclosed, customers can still access mySugr's apps through other manufacturers' devices, and some who downloaded the app in certain markets, including Germany, can get Roche's Accu-Chek brand glucose meters free of charge.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.